<code id='0B889D7E84'></code><style id='0B889D7E84'></style>
    • <acronym id='0B889D7E84'></acronym>
      <center id='0B889D7E84'><center id='0B889D7E84'><tfoot id='0B889D7E84'></tfoot></center><abbr id='0B889D7E84'><dir id='0B889D7E84'><tfoot id='0B889D7E84'></tfoot><noframes id='0B889D7E84'>

    • <optgroup id='0B889D7E84'><strike id='0B889D7E84'><sup id='0B889D7E84'></sup></strike><code id='0B889D7E84'></code></optgroup>
        1. <b id='0B889D7E84'><label id='0B889D7E84'><select id='0B889D7E84'><dt id='0B889D7E84'><span id='0B889D7E84'></span></dt></select></label></b><u id='0B889D7E84'></u>
          <i id='0B889D7E84'><strike id='0B889D7E84'><tt id='0B889D7E84'><pre id='0B889D7E84'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:975
          Mike Belleme for STAT

          Five years after investor-owned HCA Healthcare took over an esteemed nonprofit hospital in North Carolina, Medicare is threatening to cut off payment for any services it provides seniors.

          The rare and dramatic move follows a Medicare revelation that patient safety is in “immediate jeopardy” at Mission Hospital in Asheville. That designation is the most severe the agency can hand out. HCA has just a few weeks to fix the problems or lose its Medicare funding.

          advertisement

          “If on average Medicare pays roughly one-third of your revenue, if they stop paying you, you will die,” said Michael Millenson, a national patient safety expert and president of the consultancy Health Quality Advisors. “That’s why it gets immediate attention from the hospital management, because it’s a death threat.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          First over
          First over

          Opill,thefirstover-the-counterbirthcontrolpill, isonitswaytoU.S.stores.PerrigoviaAPWASHINGTON—Thefir

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

          WhatdoesitmeantoabadCEO?Canbiotechendureanotherelectionyear?AndcanyougototoomanyJ.P.Morganparties?We